Phocas Financial Corp. Mirum Pharmaceuticals, Inc. Transaction History
Phocas Financial Corp.
- $26.2 Billion
- Q3 2024
A detailed history of Phocas Financial Corp. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 37,889 shares of MIRM stock, worth $1.57 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,889
Previous 60,399
37.27%
Holding current value
$1.57 Million
Previous $2.07 Million
28.43%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$273 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$186 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$143 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$134 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$128 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.53B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...